Stockreport

Albireo Reports Data on Pharmacodynamic Marker for A4250 in Children with Cholestatic Liver Disease at The International Liver Congress™ 2018

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF — Correlation observed between reduction in serum bile acids and autotaxin with A4250 — — Autotaxin has potential to be important biomarker of cholestatic pruritus — B [Read more]